Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse  by Norata, Giuseppe Danilo et al.
Biochimica et Biophysica Acta 1822 (2012) 927–935
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isEffect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null
mutant mouse
Giuseppe Danilo Norata a,b,⁎, Vivek Krishna Pulakazhi Venu a, Elisa Callegari a,
Valentina Paloschi a, Alberico Luigi Catapano a,b,c,⁎⁎
a Department of Pharmacological Sciences, Università degli Studi di Milano, Italy
b Center for the Study of Atherosclerosis, Società Italiana Studio Aterosclerosi, Ospedale Bassini, Cinisello Balsamo, Italy
c IRCCS Multimedica, Milan, Italy⁎ Correspondence to: G.D. Norata, Department
University of Milan, Via Balzaretti 9, 20133, Milan, It
fax: +39 02 50318386.
⁎⁎ Correspondence to: A.L. Catapano, Department
University of Milan, Via Balzaretti 9, 20133, Milan, It
fax: +39 02 50318386.
E-mail addresses: Danilo.Norata@unimi.it (G.D. No
Alberico.Catapano@unimi.it (A.L. Catapano).
0925-4439/$ – see front matter © 2012 Elsevier B.V. All
doi:10.1016/j.bbadis.2012.02.014a b s t r a c ta r t i c l e i n f oArticle history:
Received 3 November 2011
Received in revised form 26 January 2012
Accepted 14 February 2012
Available online 22 February 2012
Keywords:
BNDF
Atherosclerosis
Vascular disorderThe reduced expression (haplodeﬁciency) of the main brain derived neurotrophic factor receptor, namely
TrkB is associated with reduced atherosclerosis, smooth muscle cells accumulation and collagen content in
the lesion. These data support the concept that brain derived neurotrophic factor of vascular origin may
contribute to atherosclerosis. However, to date, no experimental approach was possible to investigate this
issue due to the lethality of brain derived neurotrophic factor null mice. To overcome these limitations, we
generated a mouse model with a conditional deletion of brain derived neurotrophic factor in endothelial
cells (Tie-2 Cre recombinase) on an atherosclerotic prone background (apolipoprotein E knock out) and
investigated the effect of conditional brain derived neurotrophic factor deﬁciency on atherosclerosis. Despite
brain derived neurotrophic factor reduction in the vascular wall, mice with conditional deletion of brain
derived neurotrophic factor did not develop larger atherosclerotic lesion compared to controls. Smooth
muscle cell content as well as the distribution of total and ﬁbrillar collagen was similar in the atherosclerotic
lesions from mice with brain derived neurotrophic factor conditional deﬁciency compared to controls. Finally
an extended gene expression analysis failed to identify pro-atherogenic gene expression patterns among the
animal with brain derived neurotrophic factor deﬁciency. In spite of the reduced brain derived neurotrophic
factor expression, similar atherosclerosis development was observed in the brain derived neurotrophic factor
conditional deﬁcient mouse compared to controls. These pieces of evidence indicate that endothelial derived-
brain derived neurotrophic factor is not a pro-atherogenic factor and would rather suggest to investigate the
role of other TrkB activators on atherosclerosis.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The growth factor/receptor system of the brain derived neuro-
trophic factor (BDNF) and its receptor, the TrkB receptor, has been
proposed as a critical player of lesion development during atherogen-
esis [1]. BDNF expression was observed in human and mouse athero-
sclerotic plaques mainly in extracellular matrix area [1-3]. Alteration
of BDNF plasma levels in acute coronary syndromes was reported
although the issue is controversial [3-5].
Previous studies demonstrated that BDNF gene targeted mice
exhibit vascular hemorrhage and early postnatal lethality [6] andof Pharmacological Sciences,
aly. Tel.: +39 02 50318313;
of Pharmacological Sciences,
aly. Tel.: +39 02 50318302;
rata),
rights reserved.that BDNF is critical for perinatal vessel stabilization through the acti-
vation of TrkB receptors [7]. Furthermore TrkB reduced expression
(haplodeﬁciency) is associated with reduced atherosclerosis, smooth
muscle cell accumulation and collagen content in the lesion [1]. While
these observations suggest that TrkB receptor contributes to the
development of atherosclerotic lesions through the modulation of
smooth muscle cell function, the role of BDNF still remains elusive.
Indeed, the key demonstration that BDNF deﬁciency is associated
with increased atherosclerosis is lacking due to the impaired survival
of BDNF null mice [6]. The origin of vascular BDNF is debated as plate-
let BDNF does not appear to be acquired from the megakaryocytes or
the pituitary gland but from other sources via the blood circulation
[8]. Endothelial cells can be a source of the neurotrophin [9] and
also a target of BDNF/TrkB-mediated angiogenesis [10]. Also cells of
hematological origin such as activated T cells, B cells and monocytes
have been shown to produce BDNF in vitro and in vivo, at least in
the brain [11]. Finally to a minor extent, passage through the brain
blood barrier occurs [8]. These data suggest the possibility that
BDNF of endothelial and/or hematopoietic origin could play a role in
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sclerosis. To test this hypothesis, we generated a conditioned mouse
model where, BDNF expression is selectively deleted in Tie2-CRE
expressing cells on the background of apolipoprotein E knock out
mice. Tie2 mediated Cre-recombinase expression has been extensive-
ly characterized and efﬁciently mediates recombination in endotheli-
al cells and also in some hematopoietic cell in appropriate reporter
mice [12-14]. Therefore, we evaluated atherosclerotic aortic lesion
morphology and vascular gene expression patterns in Tie2-CRE;
BDNFﬂoxed/ﬂoxed;ApoE Knock out mice (which are deﬁcient in
BDNF in the endothelium) compared to BDNFﬂoxed/ﬂoxed;ApoE
Knock-out mice or Tie2-CRE;ApoE Knock out mice.
2. Material and methods
Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out mice were generat-
ed by crossing Tie2-CRE mice (the Jackson Laboratories, Bar Harbour,
Maine, USA; Strain name: B6.Cg-Tg[Tek-cre]1Ywa/J; Stock number:
008863) with ApoE Knock-out mice (the Jackson Laboratories; Strain:
B6.129P2-Apoetm1Unc/J; Stock number: 002052) to obtain Tie2-CRE;
ApoE Knock out animals and by crossing for eight generation
BDNFﬂoxed/ﬂoxed (the Jackson Laboratories; Strain name: STOCK
bdnftm3Jae/J; Stock number: 004339) mice with ApoE Knock-out
mice to obtain BDNFﬂoxed/ﬂoxed;ApoE Knock-out animals on
C57Bl6/J background. Next Tie2-CRE;ApoE Knock out were crossed
with BDNFﬂoxed/ﬂoxed;ApoE Knock-out mice for at least six genera-
tion to obtain littermates being either Tie2-CRE;BDNFﬂoxed/ﬂoxed;
ApoE Knock out, BDNFﬂoxed/ﬂoxed;ApoE Knock out or Tie2-CRE;
ApoE Knock out. Each genotype was evaluated following PCR
ampliﬁcation for speciﬁc DNA sequences, according to the protocols
available here; ApoE: http://jaxmice.jax.org/strain/002052.html;
BDNFﬂoxed/ﬂoxed: http://jaxmice.jax.org/strain/004439.html; Tie-CRE:
http://jaxmice.jax.org/strain/008863.html.
The investigation conforms to the European Commission Directive
86/609/EEC and was approved by the local ethical committee
(Progetto di Ricerca 2009/3). At 8 weeks of age, animals were fed ad
libitum with western type diet (21% fat, 0.15% cholesterol and 19.5%
casein, Harlan, Bresso, Italy) for 16 weeks. Mice were sacriﬁced with
an overdose of Avertin 2.5% (Aldrich Chemical Co.USA), followed by
cervical dislocation. The heart and the arterial tree were perfused with
saline solution under physiological pressure. Then the aortas and the
hearts were isolated and parafﬁn embedded [15], while the aorta
(from the last part of the ascending up to the thoracic aorta) was placed
in a storing solution (RNA laterICEtm, Ambion, Germany) at−20 °C or
ad used for conﬁrming through Q-PCR data from the cDNA microarray
analysis. For RNA isolation the samples were homogenized in a
dismembrator (Qiagen, Milan, Italy) then processed as described [16].
2.1. Plasma lipid analysis and quantiﬁcation of atherosclerosis
Blood samples were collected in EDTA tubes immediately before
death by retro-orbital bleeding and plasma was separated by low-
speed centrifugation at 4 °C. The measurement of plasma lipids was
performed by standard enzymatic techniques (ABX for Cobas Mira
Plus, Montpellier, France) [17]. Cross sequential sections 5 μm thick
were prepared from the aortic root up to 150 μm after the valve leaf-
lets were no longer detectable. For the aortic sinus and the ascending
aorta the slides were stained with hematoxylin–eosin, for each tract
of the aorta 15 sections were analyzed. Images of the aortas were
captured with Axiovert 200 microscope and the atherosclerotic lesion
area was quantiﬁed by computer image analysis, using Axiovision LE
rel 4.4 software by two blinded observers as described [17]. The
quantiﬁcation of the collagen content was performed following
picro-sirius red staining, images of the aortas were captured with
Axiovert 200 microscope (ZEISS, Milan, Italy) under regular and po-
larized light, then ﬁbrillar collagen, detected by yellow birefringence,was quantiﬁed using Image J analysis software, capable of color seg-
mentation and automation by programmable macros, by two blinded
observers. Data are expressed as the percentage of the total athero-
sclerotic lesion area covered by ﬁbrillar collagen±standard error.
2.2. cDNA microarray analysis
A comprehensive gene expression analysis was performed in the
tract of the aorta between the aortic sinus and the ascending aorta
where the morphometric analysis was performed as described [17]
and is summarized in the Supplementary material section. The cDNA
microarray experiments were performed according to the Minimum
Information About a Microarray Experiment (MIAME) guidelines [18],
the raw data for each hybridization and the ﬁnal processed ﬁles are ac-
cessible at the following address: http://www.sisalombardia.it/dati4/
dati4.htm. RNA was extracted from the aorta using the kit RNAeasy
Formalin-ﬁxed, parafﬁn-embedded (FFPE) tissue sections from Qiagen
(Milan, Italy). The quality of the RNA was tested with standard proce-
dures. Five hundredmicrograms of RNAwere then used for RNA ampli-
ﬁcation using the SuperScript RNA Ampliﬁcation System (Invitrogen,
Italy) according to the manufacturer's instructions. Two micrograms
of ampliﬁed RNA was then processed for microarray experiments
while the remaining was used for validation with Q-PCR as described
below. For microarray experiments Dual Chip Mouse Inﬂammation
microarray was used (Eppendorf, Italy). Biotin 11-dATP and biotin
11-cCTP cDNA were synthesized according to the protocol from the
manufacturer and hybridized to themicroarrays. For these experiments
the gene expression pattern in male and female was investigated sepa-
rately. The arrays were developed with the Silverquant Detection Kit
(Eppendorf, Italy), the images were acquired with the Silverquant De-
tection Software and analyzed with the Silverquant Analysis Software
(Eppendorf, Italy). Data are expressed as fold of induction of Tie2-CRE;
BDNFﬂoxed/ﬂoxed;ApoE Knock out or BDNFﬂoxed/ﬂoxed;ApoE Knock
out vs Tie2-CRE;ApoE Knock out. For each group, four replicates, each
resulting from pooling the mRNA of three animals were analyzed.
2.3. Real time quantitative polymerase chain reaction
Total RNA was reverse transcribed as described [19,20]. Three mi-
croliters of cDNA were ampliﬁed by real-time quantitative PCR with
1× Syber green universal PCR mastermix (BioRad, Italy). The speciﬁc-
ity of the Syber green ﬂuorescence was tested as described [19]. The
primers used have been described previously [15]. Each sample was
analyzed in duplicate using the IQTM-Cycler (BioRad). The PCR am-
pliﬁcation was related to a standard curve ranging from 10–11 mol/L
to 10–14 mol/L and data were normalized for the housekeeping
gene ribosomal protein L13a (RLP13a) (NM_009438).
2.4. Immunohistochemistry
For macrophage, smooth muscle cell and T-lymphocyte detection,
rat anti mouse F4/80 (antigen, AbD Serotec, Oxford, UK, dilution
1:100), rabbit polyclonal to CD3 and rabbit polyclonal to smoothmuscle
actin (Abcam, Cambridge UK, dilution 1:50 and 1:100 respectively), or
non-immune IgG as a control was used (4 °C overnight) followed by
incubation with a secondary biotinylated antibody (anti-rabbit IgG or
anti-rat IgG, Vector Laboratories, Burlingame, CA, USA, diluted 1:200
in 1% normal goat serum and PBS) for 1 h at room temperature.
Immunoreactivity was visualized using avidin–biotin–peroxidase
method (Vectastain ABC kit from Vector Laboratories, Burlingame, CA,
USA) with 3,3′-diaminobenzidine substrate (Sigma, Italy) as the
chromogen. Dehydrated sections were observed using Zeiss Axioskop
microscope (Zeiss) and analyzed with color-video image analysis
system linked to themicroscope; for the quantiﬁcation of the immuno-
reactive area the Image J analysis software, capable of color deconvolu-
tion and segmentation by programmable macros, was used.
929G.D. Norata et al. / Biochimica et Biophysica Acta 1822 (2012) 927–9352.5. Statistics
Data were analyzed using SPSS 16.0 for Windows (SPSS, Chicago,
IL) with two way ANOVA followed by Scheffe contrast. When histo-
logical data were compared between groups, parametric t-tests set-
ting the signiﬁcance level at pb0.05 were used and to compensate
for a potential lack of normal distribution, nonparametric Wilcoxon
tests were applied.
3. Results
3.1. Characterization of Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out mice
Preliminary experiments showed no difference on atherosclerosis
burden in Tie2-CRE;ApoE Knock out or BDNFﬂoxed/ﬂoxed;ApoE
Knock out compared to ApoE knock out animals (data not shown);BDNF-
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Fig. 1. Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out characterization. Panels A to D. CRE reco
BDNFloxed;ApoE−/− (panels C and D) (negative controls are presented in panels A and C)
aortas from BDNFﬂoxed/ﬂoxed;ApoE−/− and Tie2 CRE;BDNFﬂoxed/ﬂoxed;ApoE−/−mice
of the reference gene RLP13a (n=6 for each group; mean±S.E., * pb0.01 vs BDNFﬂoxed/ﬂtherefore in all experiments Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE
Knock out mice were compared to Tie2-CRE;ApoE Knock out and
BDNFﬂoxed/ﬂoxed;ApoE Knock out mice. We ﬁrst investigated
Cre-recombinase expression which was selectively observed at the
endothelial level (Fig. 1) in agreement with previous ﬁndings [13].
In Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out mice, BDNF mRNA
levels were reduced in the aorta compared to Tie2-CRE;ApoE Knock
out and BDNFﬂoxed/ﬂoxed;ApoE Knock out (from approximately
9000 to 300 mRNA copies relative to 105 copies of the housekeeping
gene); on the contrary the expression of endothelial nitric oxide
(eNOS), was not altered (Fig. 1). The analysis of BDNF and eNOS
expression in mRNA from blood cells showed no differences among
the animals of the different genotypes (data not shown), thus exclud-
ing the potential impact of Tie-2 mediated deletion in hematopoietic
cells. These ﬁndings support the hypothesis that endothelial-derived
BDNF signiﬁcantly contributes to BDNF expression in the vascularD
CRE-recombinase
2-CRE;BDNFloxed;ApoE-/-
NFloxed;ApoE-/-
*
BDNF eNOS
B
mbinase staining is shown for BDNFloxed;ApoE−/− (panels A and B) and for Tie2-CRE;
. Arrows indicate positivity on the endothelium. Panel E. BDNF mRNA expression in the
. Results are presented as relative number of mRNA copies every 100,000 mRNA copies
oxed;ApoE−/−).
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ApoE Knock out mice was reduced mainly in the sub-endothelial
space compared to Tie2-CRE;ApoE Knock out and BDNFﬂoxed/
ﬂoxed;ApoE Knock out; the expression of TRK-B, although low and
diffused, was not affected (Supplementary Figure I). When plasma,
serum levels or tissue levels of BDNF were analyzed with ELISA or
western blotting, no detectable levels were recorded (data not
shown), in agreement with previous papers suggesting that the
detection of BDNF protein levels in mice is, up to date, technically
limited [21,22].
3.2. Quantitative morphometry of atherosclerosis in Tie2-CRE;
BDNFﬂoxed/ﬂoxed;ApoE Knock out mice
After feeding the animals for 16 weeks with western type diet, no
signiﬁcant differences were observed in body weight or plasma lipid
levels (Table 1). Overall female developed larger atherosclerotic
lesions as compared to male mice (Table 1) which is in agreement
with previous observations [17,23].
Atherosclerotic lesion area in the aortic sinus was not signiﬁcantly
different among Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out mice
and Tie2-CRE;ApoE Knock out or BDNFﬂoxed/ﬂoxed;ApoE Knock
out mice (Table 1 and Fig. 2). This was true even when in a subgroup
of animals (four per group, two male and two female) atherosclerotic
lesion area was measured throughout the ﬁrst 200 μm of the aorta
starting from the cuspids (Figure III, Supplementary material). Finally,
no atherosclerotic lesions were detected in the thoracic and
abdominal aorta in each group (Figure II, Supplementary material).
Atherosclerosis development was also assessed in animals fed the
atherogenic diet for 8 weeks or 36 weeks. Even at an early or at a
later time point, atherosclerotic lesion area in the aortic sinus was
not signiﬁcantly different among Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE
Knock out mice or BDNFﬂoxed/ﬂoxed;ApoE Knock out mice (Figure
IV, Supplementary material).
3.3. Atherosclerotic plaque characterization in Tie2-CRE;BDNFﬂoxed/
ﬂoxed;ApoE Knock out mice
As haplodeﬁcient expression of TRK-B is associated with altered
cell accumulation in the atherosclerotic lesions [1], we investigated
the presence of smooth muscle cells (SMC) (Fig. 3B,G,L), of macro-
phages (Fig. 3E, J, O) and of T lymphocytes (Fig. 3C,H,M) in the ath-
erosclerotic plaque from Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE knock
out mice (Fig. 3 panels A to E), from Tie2-CRE;ApoE Knock out
(Fig. 3 panels F to J) and from BDNFﬂoxed/ﬂoxed;ApoE Knock outTable 1
Effects of 16 weeks of atherogenic diet on body weights, on plasma lipids and on
atherosclerotic lesions in Tie2-CRE/BDNFﬂoxed/ﬂoxed ApoE knock out mice compared
to their controls according to the gender.
Tie2-CRE BDNFﬂoxed/
ﬂoxed ApoE−/−
Tie2-CRE
ApoE−/−
BDNFﬂoxed/
ﬂoxed ApoE−/−
(n=6) (n=6) (n=6)
Male
Body weight at death, g 37.9±4.2§ 33.8±3.9 36.1±4.7
Weight gain, g 18.3±4.6 16.5±1.3 17.4±3.2
Cholesterol, mg/dL 785±117 690±173 769±159
Triglyceride, mg/dL 97±40 118±50 105±35
Aortic sinus lesion, mm2 0.24±0.04 0.22±0.08 0.21±0.09
Female
Body weight at death, g 27.1±6.3 25.5±4.4 28.2±4.7
Weight gain, g 9.8±3.1 9.8±2.9 10.3±1.5
Cholesterol, mg/dL 1112±302 1032±235 923±302
Triglyceride, mg/dL 115±30 104±40 110±21
Aortic sinus lesion, mm2 0.38±0.12 0.34±0.12 0.36±0.10
No signiﬁcant differences among animal groups were observed.mice (Fig. 3 panels K to O) fed for 16 weeks with the western type
diet. Although several smooth muscle cells, macrophages and, a limit-
ed amount of T-lymphocytes, were detected in the atherosclerotic
plaques, no major differences among the animal groups were
observed (SMC: 22.5±7.8% for Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE
knock out mice vs 20.4±6.5% for Tie2-CRE;ApoE Knock out and
25.9±8.1%; macrophages: 9.3±7.1%, 13.5±4.8% and 15.6±3.2% re-
spectively; T cells: 4.2±3.2%, 5.5±2.7% and 7.2±5.6% respectively).
To further conﬁrm these observations, mRNA was extracted from
formalin-ﬁxed-parafﬁn embedded slides next to those stained and a
comprehensive gene expression analysis of speciﬁc markers of the
cells present during the development of atherosclerosis in the vascu-
lar wall was performed as described by Veillard et al. [24]. Similar
levels of mRNA for CD68 (a marker of monocyte/macrophages) and
of mRNA for CD4 (a T-helper lymphocytes (Th) marker) were ob-
served within the vascular wall of the aortic arch of the three groups
of animals (Fig. 3P). In addition the expression of mRNA for TIM3
probe (T-cell immunoglobulin domain, mucin domain), a marker of
Th1 cells, or of chemokine receptor CCR4, a marker highly expressed
in Th2 and regulatory T lymphocytes cells [24] was not different with-
in the vascular wall of the aortic arch of the three groups of animals
(Fig. 3P). Finally also the mRNA expression of α-actin, a marker of
smooth muscle cells, resulted similar in all mice groups (Fig. 3P).
While these data suggest that Tie-2 conditional deletion of BDNF is
not associated with increased atherosclerosis, they do not exclude
the possibility that BDNF selective deﬁciency would be associated
with altered vascular gene expression patterns. We therefore used a
mouse inﬂammation focussed cDNA microarray to investigate the
mRNA expression on the tract between the aortic sinus and the
ascending aorta in mice fed for 16 weeks with western type diet
(Fig. 4). When data were analyzed using either Tie2-CRE;ApoE
Knock out or BDNFﬂoxed/ﬂoxed;ApoE Knock out as reference group,
among the genes present in the array, only a minor number appeared
to be modulated in Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE knock out
mice. Furthermore, genes that resulted up or downregulated vs the
Tie2-CRE;ApoE Knock out group were not modulated when data
were compared vs the BDNFﬂoxed/ﬂoxed;ApoE Knock out group. To
gain further insight into genes potentially involved in atherogenesis,
the mRNA expression of adhesion molecules such as ICAM-1,
VCAM-1 and of cytokines/chemokines such as MCP-1, IL-6 and IL10
was evaluated by Q-PCR (Fig. 3Q). Again no relevant differences
were observed among the three groups which support the lack of
any relevant effect of endothelial BDNF deﬁciency on vascular inﬂam-
matory processes.
This does not exclude the possibility that despite similar SMC
presence, those could differently affect plaque stability through the
synthesis of collagen [25]; we therefore investigated the mRNA ex-
pression of the main collagen isoforms and the collagen distribution
in the vascular wall (Fig. 5). No signiﬁcant differences were
observed in total collagen or ﬁbrillar collagen distribution in the
aortic sinus, furthermore mRNA expression of collagen 1A1, collagen
1A2 and collagen 3A1 was not signiﬁcantly different between groups.
Altogether these ﬁndings suggest that endothelial deﬁciency of BDNF
is not associated with reduced atherosclerosis.
4. Discussion
BDNF plays a key role as an endothelial survival factor and
supports angiogenesis through the activation of TrkB receptors
[6,10,26]. TrkB reduced expression (haplodeﬁciency) is associated
with a limited but signiﬁcant reduction in atherosclerosis, smooth
muscle cell accumulation and collagen content in the lesion [1].
Those data support the possibility that BDNF of vascular origin may
contribute to atherosclerosis. However, to date, no experimental
approach was possible to investigate this issue due to the lethality
of BDNF null mice. To overcome this limitation, we generated an
0 6 Female
Tie2-CRE/BDNF-floxed 
APOE -/-
Tie2-CRE 
APOE -/-
A
BDNF-floxed 
APOE -/-
0,3
0,4
0,5
,
0
0,1
0,2
B
BDNFfloxed 
ApoE-/-
Tie2-CRE 
BDNF-floxed
ApoE-/-
Tie2-CRE 
ApoE-/-
Le
sio
n 
ar
ea
 m
m
2
Le
sio
n 
ar
ea
 m
m
2
0,3
0,4 Male
0,1
0,2
BDNFfloxed 
ApoE-/-
Tie2-CRE 
BDNFfloxed
ApoE-/-
Tie2-CRE 
ApoE-/-
0
C
Fig. 2. Aortic sinus atherosclerosis in Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out, Tie2-CRE;ApoE Knock out and BDNFﬂoxed/ﬂoxed;ApoE Knock out mice. Representative sections
of the aortic sinus stained with hematoxylin and eosin, for Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out, Tie2-CRE;ApoE Knock out and BDNFﬂoxed/ﬂoxed;ApoE Knock out mice are
shown in panel A. Scale bar 100 μm. Data are shown for female mice. The extent of the atherosclerotic lesion in those animals for aortic sinus in female andmale is shown in panels B
and C (n=6 for each group), and is expressed as mean±S.D.) (differences among groups are not statistically signiﬁcant).
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BDNF in endothelial cells which efﬁciently results in a reduction of
BDNF expression in the vascular wall.
Unexpectedly mice with endothelial conditional deletion of BDNF
did not develop larger atherosclerotic lesion compared to controls.
Furthermore, the presence of smooth muscle cells is similar in mice
with BDNF conditional deletion and controls as it is the distribution
of total collagen or ﬁbrillar collagen in the atherosclerotic lesions in
spite of data in TrkB haplodeﬁcient mice where a reduced smooth
muscle cell accumulation [1] was observed. Finally an extended
gene expression analysis failed to identify altered inﬂammatory
gene expression patterns in mice with BDNF conditional deﬁciency
compared to controls.As TrkB haplodeﬁciency has been demonstrated to protect against
atherosclerosis in mice, our data would imply that TrkB engagement
by factors other than endothelial-derived BDNF could be involved in
smooth muscle cell accumulation and atherosclerosis. More impor-
tantly, in addition to other neurotrophins such as NT-4, spectra of
TrkB activators are emerging [27], including ephrin-A5 or low-
density lipoprotein receptor-related protein 1 (LRP-1). NT4 [26],
ephrin-A5 [28] and LRP-1 [29] appear to be key players in the modu-
lation of cell recruitment, survival or apoptosis in the cardiovascular
system thus supporting the possibility also of BDNF-independent,
TrkB-mediated effects in atherogenesis.
In summary, the generation of a Tie-2 Cre recombinase conditional
mouse model on a pro-atherogenic background, allowed to overcome
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Fig. 3. Macrophage, smooth muscle cell and T-lymphocyte presence in the atherosclerotic lesions and relative expression of inﬂammatory mediators and their receptors in the
vascular wall. Panels A to O. F4/80 (macrophage), α-actin (smooth muscle cells) and CD3 (T-lymphocytes) staining is shown for female BDNFﬂoxed/ﬂoxed;ApoE Knock out
mice (panels A to E), Tie2-CRE;ApoE Knock out (panels F to J) and Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out (panels K to O) (negative controls for F4/80 are presented in panels
A, F and K; negative controls for α-actin and CD3 are presented in panels C, H and M). Panel P. Relative expression of markers of monocyte/macrophages, lymphocytes and smooth
muscle cells in the vascular wall measured by quantitative real-time RT-PCR. Relative mRNA expression (control=1) of CD68 (monocyte/macrophages), CD4 (lymphocytes
T-helper), Tim3 (lymphocytes Th1), CCR4 (lymphocytes Th2) and alpha-actin (SMC) is shown. Panel Q. Relative mRNA expression of CCL2, CX3CR1, IL6, IL10 ICAM-1, VCAM-1,
ELAM-1 and PECAM-1 is shown. In panels P and Q, results from real-time PCR are shown (fold induction vs. BDNFﬂoxed/ﬂoxed;ApoE Knock out animals (n=8 per group), corrected
for the RLP13a expression, mean±S.D.) (*pb0.05 vs. control).
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Fig. 4. cDNAmicroarray analysis for genes involved in inﬂammatory response of the aortic arch from Tie2-CRE;ApoE−/−, BDNFﬂoxed/ﬂoxed;ApoE−/−; and Tie2-CRE;BDNFﬂoxed/
ﬂoxed;ApoE−/− mice. Please see the Material and methods section for details.
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Fig. 5. Analysis of the ﬁbrillar collagen content within the atherosclerotic lesion of Tie2-CRE;BDNFﬂoxed/ﬂoxed;ApoE Knock out, Tie2-CRE;ApoE Knock out and BDNFﬂoxed/ﬂoxed;
ApoE Knock out mice. Panels A and B. Representative sections of aortic sinus stained with sirius red and following acquisition with polarized light are shown, scale bar: 100 μm.
Panel C. Percentage of the area positive for total collagen and ﬁbrillar collagen in the aortic sinus. Data are presented as the percentage of atherosclerotic lesion covered by collagen,
and are expressed as mean±S.E. (n=6 for each group). Panel D. Relative mRNA expression of collagens 1A1, 1A2 and 3A1 for the different animal groups is presented. The results,
normalized for the RLP13a expression, are shown as fold of induction vs. BDNFﬂoxed/ﬂoxed;ApoE Knock out (data are expressed as mean±S.D. The differences were not statisti-
cally signiﬁcant).
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BDNF deﬁciency on atherogenesis. BDNF conditional deﬁcient
mouse did not developed smaller atherosclerotic lesions compared
to controls. Future studies should investigate whether local overex-
pression of BDNF would affect the development of atherosclerosis or
whether BDNF deﬁciency could result in atheroprotection in ApoE
KO animals fed a chow diet. The role of BDNF in cardiovascular
disease in humans is debated [3,4], and a strong involvement in
angiogenesis was proposed [10,26]. Furthermore, a series of phar-
macological approaches aimed at modulating the BDNF/TrkB axis is
under investigation not only for neurological disorders [30] but also
for vascular disorders associated to dementia and as well as
BDNF-mediated angiogenesis [31,32]. Therefore, the data presented in
this paper, which limit the impact of endothelial derived BDNF as a
pro-atherogenic factor, support further investigations of BDNF
mimetics in vascular disorders.
Supplementary materials related to this article can be found
online at doi:10.1016/j.bbadis.2012.02.014.Conﬂict of interest statement
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